Regulation of microRNA expression in vascular smooth muscle by MRTF-A and actin polymerization

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1864, Issue 6, 2017, Pages 1088-1098

  Alajbegovic, Azra ^a   Turczyńska, Karolina M ^a   Hien, Tran Thi ^a   Cidad, Pilar ^b   Swärd, Karl ^a   Hellstrand, Per ^a   Della Corte, Alessandro ^c   Forte, Amalia ^c   Albinsson, Sebastian ^a  

^a LUND UNIVERSITY   (Sweden)

^b University of Valladolid   (Spain)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Actin polymerization; MicroRNA; MRTF A; Phenotype; Smooth muscle; Vascular disease

Indexed keywords

CYTOSKELETON PROTEIN; F ACTIN; G ACTIN; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 143; MICRORNA 145; MICRORNA 22; MICRORNA 378A; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; ACTIN; MKL1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; BICUSPID AORTIC VALVE; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CELL ADHESION; CORONARY ARTERY MUSCLE; DEPOLYMERIZATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CODE; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA STABILITY; SMOOTH MUSCLE CELL; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; POLYMERIZATION;

ACTINS; ANIMALS; CELLS, CULTURED; GENE EXPRESSION PROFILING; HUMANS; MICE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; POLYMERIZATION; TRANS-ACTIVATORS;

EID: 85008157645     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2016.12.005     Document Type: Article

References (80)

1. [1] Somlyo, A.P., Somlyo, A.V., Signal transduction and regulation in smooth muscle. Nature 372 (1994), 231–236.
2. [2] Fernandez-Tenorio, M., Porras-Gonzalez, C., Castellano, A., Del Valle-Rodriguez, A., Lopez-Barneo, J., Urena, J., Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2 + channels: new mechanism for depolarization-evoked mammalian arterial contraction. Circ. Res. 108 (2011), 1348–1357.
3. [3] Urena, J., Lopez-Barneo, J., Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2 + channels. Trends Cardiovasc. Med. 22 (2012), 155–160.
4. [4] Ren, J., Albinsson, S., Hellstrand, P., Distinct effects of voltage- and store-dependent calcium influx on stretch-induced differentiation and growth in vascular smooth muscle. J. Biol. Chem. 285 (2010), 31829–31839.
5. [5] Wamhoff, B.R., Bowles, D.K., McDonald, O.G., Sinha, S., Somlyo, A.P., Somlyo, A.V., Owens, G.K., L-type voltage-gated Ca2 + channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ. Res. 95 (2004), 406–414.
6. [6] Ying, Z., Giachini, F.R., Tostes, R.C., Webb, R.C., PYK2/PDZ-RhoGEF links Ca2 + signaling to RhoA. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 1657–1663.
7. [7] Fukata, Y., Amano, M., Kaibuchi, K., Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22 (2001), 32–39.
8. [8] Pollard, T.D., Borisy, G.G., Cellular motility driven by assembly and disassembly of actin filaments. Cell 112 (2003), 453–465.
9. [9] Miralles, F., Posern, G., Zaromytidou, A.I., Treisman, R., Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113 (2003), 329–342.
10. [10] Sotiropoulos, A., Gineitis, D., Copeland, J., Treisman, R., Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98 (1999), 159–169.
11. [11] Mack, C.P., Somlyo, A.V., Hautmann, M., Somlyo, A.P., Owens, G.K., Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J. Biol. Chem. 276 (2001), 341–347.
12. [12] Wang, Z., Wang, D.Z., Pipes, G.C., Olson, E.N., Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 7129–7134.
13. [13] Wang, D.Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J.A., Nordheim, A., Olson, E.N., Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 14855–14860.
14. [14] Miano, J.M., Serum response factor: toggling between disparate programs of gene expression. J. Mol. Cell. Cardiol. 35 (2003), 577–593.
15. [15] Albinsson, S., Hellstrand, P., Integration of signal pathways for stretch-dependent growth and differentiation in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 293 (2007), C772–C782.
16. [16] Albinsson, S., Nordstrom, I., Hellstrand, P., Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization. J. Biol. Chem. 279 (2004), 34849–34855.
17. [17] Lockman, K., Hinson, J.S., Medlin, M.D., Morris, D., Taylor, J.M., Mack, C.P., Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J. Biol. Chem. 279 (2004), 42422–42430.
18. [18] Hinson, J.S., Medlin, M.D., Lockman, K., Taylor, J.M., Mack, C.P., Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. Am. J. Physiol. Heart Circ. Physiol. 292 (2007), H1170–H1180.
19. [19] Minami, T., Kuwahara, K., Nakagawa, Y., Takaoka, M., Kinoshita, H., Nakao, K., Kuwabara, Y., Yamada, Y., Yamada, C., Shibata, J., Usami, S., Yasuno, S., Nishikimi, T., Ueshima, K., Sata, M., Nakano, H., Seno, T., Kawahito, Y., Sobue, K., Kimura, A., Nagai, R., Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. EMBO J. 31 (2012), 4428–4440.
20. [20] Weise-Cross, L., Taylor, J.M., Mack, C.P., Inhibition of diaphanous formin signaling in vivo impairs cardiovascular development and alters smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 2374–2383.
21. [21] Shen, D., Li, J., Lepore, J.J., Anderson, T.J., Sinha, S., Lin, A.Y., Cheng, L., Cohen, E.D., Roberts, J.D. Jr., Dedhar, S., Parmacek, M.S., Gerszten, R.E., Aortic aneurysm generation in mice with targeted deletion of integrin-linked kinase in vascular smooth muscle cells. Circ. Res. 109 (2011), 616–628.
22. [22] Weinl, C., Riehle, H., Park, D., Stritt, C., Beck, S., Huber, G., Wolburg, H., Olson, E.N., Seeliger, M.W., Adams, R.H., Nordheim, A., Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. J. Clin. Invest. 123 (2013), 2193–2206.
23. [23] Weinl, C., Castaneda Vega, S., Riehle, H., Stritt, C., Calaminus, C., Wolburg, H., Mauel, S., Breithaupt, A., Gruber, A.D., Wasylyk, B., Olson, E.N., Adams, R.H., Pichler, B.J., Nordheim, A., Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 9914–9919.
24. [24] Guo, D.C., Papke, C.L., Tran-Fadulu, V., Regalado, E.S., Avidan, N., Johnson, R.J., Kim, D.H., Pannu, H., Willing, M.C., Sparks, E., Pyeritz, R.E., Singh, M.N., Dalman, R.L., Grotta, J.C., Marian, A.J., Boerwinkle, E.A., Frazier, L.Q., LeMaire, S.A., Coselli, J.S., Estrera, A.L., Safi, H.J., Veeraraghavan, S., Muzny, D.M., Wheeler, D.A., Willerson, J.T., Yu, R.K., Shete, S.S., Scherer, S.E., Raman, C.S., Buja, L.M., Milewicz, D.M., Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am. J. Hum. Genet. 84 (2009), 617–627.
25. [25] Leitner, L., Shaposhnikov, D., Mengel, A., Descot, A., Julien, S., Hoffmann, R., Posern, G., MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeleton-associated proteins. J. Cell Sci. 124 (2011), 4318–4331.
26. [26] Medjkane, S., Perez-Sanchez, C., Gaggioli, C., Sahai, E., Treisman, R., Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell Biol. 11 (2009), 257–268.
27. [27] Selvaraj, A., Prywes, R., Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Mol. Biol., 5, 2004, 13.
28. [28] Turczynska, K.M., Sward, K., Hien, T.T., Wohlfahrt, J., Mattisson, I.Y., Ekman, M., Nilsson, J., Sjogren, J., Murugesan, V., Hultgardh-Nilsson, A., Cidad, P., Hellstrand, P., Perez-Garcia, M.T., Albinsson, S., Regulation of smooth muscle dystrophin and synaptopodin 2 expression by actin polymerization and vascular injury. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1489–1497.
29. [29] Sun, Q., Chen, G., Streb, J.W., Long, X., Yang, Y., Stoeckert, C.J. Jr., Miano, J.M., Defining the mammalian CArGome. Genome Res. 16 (2006), 197–207.
30. [30] Zhao, J., Zhang, W., Lin, M., Wu, W., Jiang, P., Tou, E., Xue, M., Richards, A., Jourd'heuil, D., Asif, A., Zheng, D., Singer, H.A., Miano, J.M., Long, X., MYOSLID is a novel serum response factor-dependent long noncoding RNA that amplifies the vascular smooth muscle differentiation program. Arterioscler. Thromb. Vasc. Biol., 2016.
31. [31] Krol, J., Loedige, I., Filipowicz, W., The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11 (2010), 597–610.
32. [32] Albinsson, S., Skoura, A., Yu, J., Dilorenzo, A., Fernandez-Hernando, C., Offermanns, S., Miano, J.M., Sessa, W.C., Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One, 6, 2011, e18869.
33. [33] Albinsson, S., Suarez, Y., Skoura, A., Offermanns, S., Miano, J.M., Sessa, W.C., MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 1118–1126.
34. [34] Turczynska, K.M., Sadegh, M.K., Hellstrand, P., Sward, K., Albinsson, S., MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels. J. Biol. Chem. 287 (2012), 19199–19206.
35. [35] Thi Hien, T., Turczynska, K.M., Dahan, D., Ekman, M., Grossi, M., Sjogren, J., Nilsson, J., Braun, T., Boettger, T., Garcia Vaz, E., Stenkula, K., Sward, K., Gomez, M.F., Albinsson, S., Elevated glucose levels promote contractile and cytoskeletal gene expression in vascular smooth muscle via Rho/protein kinase C and actin polymerization. J. Biol. Chem., 2015.
36. [36] Boettger, T., Beetz, N., Kostin, S., Schneider, J., Kruger, M., Hein, L., Braun, T., Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119 (2009), 2634–2647.
37. [37] Xin, M., Small, E.M., Sutherland, L.B., Qi, X., McAnally, J., Plato, C.F., Richardson, J.A., Bassel-Duby, R., Olson, E.N., MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23 (2009), 2166–2178.
38. [38] Bhattachariya, A., Dahan, D., Ekman, M., Boettger, T., Braun, T., Sward, K., Hellstrand, P., Albinsson, S., Spontaneous activity and stretch-induced contractile differentiation are reduced in vascular smooth muscle of miR-143/145 knockout mice. Acta Physiol (Oxford), 2015.
39. [39] Lu, H., Fagnant, P.M., Bookwalter, C.S., Joel, P., Trybus, K.M., Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E4168–E4177.
40. [40] Lu, H., Fagnant, P.M., Krementsova, E.B., Trybus, K.M., Severe molecular defects exhibited by the R179H mutation in human vascular smooth muscle alpha-actin. J. Biol. Chem., 2016.
41. [41] Malloy, L.E., Wen, K.K., Pierick, A.R., Wedemeyer, E.W., Bergeron, S.E., Vanderpool, N.D., McKane, M., Rubenstein, P.A., Bartlett, H.L., Thoracic aortic aneurysm (TAAD)-causing mutation in actin affects formin regulation of polymerization. J. Biol. Chem. 287 (2012), 28398–28408.
42. [42] Huang, J., Wang, T., Wright, A.C., Yang, J., Zhou, S., Li, L., Small, A., Parmacek, M.S., Myocardin is required for maintenance of vascular and visceral smooth muscle homeostasis during postnatal development. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 4447–4452.
43. [43] Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D.Z., Lu, Q., Deitch, E.A., Huo, Y., Delphin, E.S., Zhang, C., MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 105 (2009), 158–166.
44. [44] Cordes, K.R., Sheehy, N.T., White, M.P., Berry, E.C., Morton, S.U., Muth, A.N., Lee, T.H., Miano, J.M., Ivey, K.N., Srivastava, D., miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460 (2009), 705–710.
45. [45] Elia, L., Quintavalle, M., Zhang, J., Contu, R., Cossu, L., Latronico, M.V., Peterson, K.L., Indolfi, C., Catalucci, D., Chen, J., Courtneidge, S.A., Condorelli, G., The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ., 2009.
46. [46] Quintavalle, M., Elia, L., Condorelli, G., Courtneidge, S.A., MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J. Cell Biol. 189 (2010), 13–22.
47. [47] Wang, X., Hu, G., Zhou, J., Repression of versican expression by microRNA-143. J. Biol. Chem. 285 (2010), 23241–23250.
48. [48] Dahan, D., Ekman, M., Larsson-Callerfelt, A.K., Turczynska, K., Boettger, T., Braun, T., Sward, K., Albinsson, S., Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility. Am. J. Physiol. Cell Physiol. 307 (2014), C1093–C1101.
49. [49] Ronkainen, J.J., Hanninen, S.L., Korhonen, T., Koivumaki, J.T., Skoumal, R., Rautio, S., Ronkainen, V.P., Tavi, P., Ca2 +-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation. J. Physiol. 589 (2011), 2669–2686.
50. [50] Lovren, F., Pan, Y., Quan, A., Singh, K.K., Shukla, P.C., Gupta, N., Steer, B.M., Ingram, A.J., Gupta, M., Al-Omran, M., Teoh, H., Marsden, P.A., Verma, S., MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126 (2012), S81–S90.
51. [51] Caruso, P., Dempsie, Y., Stevens, H.C., McDonald, R.A., Long, L., Lu, R., White, K., Mair, K.M., McClure, J.D., Southwood, M., Upton, P., Xin, M., van Rooij, E., Olson, E.N., Morrell, N.W., MacLean, M.R., Baker, A.H., A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ. Res. 111 (2012), 290–300.
52. [52] Rao, P.K., Toyama, Y., Chiang, H.R., Gupta, S., Bauer, M., Medvid, R., Reinhardt, F., Liao, R., Krieger, M., Jaenisch, R., Lodish, H.F., Blelloch, R., Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 105 (2009), 585–594.
53. [53] van der Ree, M.H., van der Meer, A.J., de Bruijne, J., Maan, R., van Vliet, A., Welzel, T.M., Zeuzem, S., Lawitz, E.J., Rodriguez-Torres, M., Kupcova, V., Wiercinska-Drapalo, A., Hodges, M.R., Janssen, H.L., Reesink, H.W., Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antivir. Res. 111 (2014), 53–59.
54. [54] Zhao, Y., Samal, E., Srivastava, D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005), 214–220.
55. [55] Imamura, M., Sugino, Y., Long, X., Slivano, O.J., Nishikawa, N., Yoshimura, N., Miano, J.M., Myocardin and microRNA-1 modulate bladder activity through connexin 43 expression during post-natal development. J. Cell. Physiol. 228 (2013), 1819–1826.
56. [56] Chen, J., Yin, H., Jiang, Y., Radhakrishnan, S.K., Huang, Z.P., Li, J., Shi, Z., Kilsdonk, E.P., Gui, Y., Wang, D.Z., Zheng, X.L., Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 368–375.
57. [57] Wystub, K., Besser, J., Bachmann, A., Boettger, T., Braun, T., miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet., 9, 2013, e1003793.
58. [58] Heidersbach, A., Saxby, C., Carver-Moore, K., Huang, Y., Ang, Y.S., de Jong, P.J., Ivey, K.N., Srivastava, D., microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife, 2, 2013, e01323.
59. [59] Jiang, Y., Yin, H., Zheng, X.L., MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J. Cell. Physiol., 2010.
60. [60] Xie, C., Huang, H., Sun, X., Guo, Y., Hamblin, M., Ritchie, R.P., Garcia-Barrio, M.T., Zhang, J., Chen, Y.E., MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 20 (2011), 205–210.
61. [61] Torella, D., Iaconetti, C., Catalucci, D., Ellison, G.M., Leone, A., Waring, C.D., Bochicchio, A., Vicinanza, C., Aquila, I., Curcio, A., Condorelli, G., Indolfi, C., MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ. Res. 109 (2011), 880–893.
62. [62] Liao, X.B., Zhang, Z.Y., Yuan, K., Liu, Y., Feng, X., Cui, R.R., Hu, Y.R., Yuan, Z.S., Gu, L., Li, S.J., Mao, D.A., Lu, Q., Zhou, X.M., de Jesus Perez, V.A., Yuan, L.Q., MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology 154 (2013), 3344–3352.
63. [63] Terentyev, D., Belevych, A.E., Terentyeva, R., Martin, M.M., Malana, G.E., Kuhn, D.E., Abdellatif, M., Feldman, D.S., Elton, T.S., Gyorke, S., miR-1 overexpression enhances Ca(2 +) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 104 (2009), 514–521.
64. [64] Belevych, A.E., Sansom, S.E., Terentyeva, R., Ho, H.T., Nishijima, Y., Martin, M.M., Jindal, H.K., Rochira, J.A., Kunitomo, Y., Abdellatif, M., Carnes, C.A., Elton, T.S., Gyorke, S., Terentyev, D., MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS One, 6, 2011, e28324.
65. [65] Gagan, J., Dey, B.K., Layer, R., Yan, Z., Dutta, A., MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J. Biol. Chem. 286 (2011), 19431–19438.
66. [66] Nagalingam, R.S., Sundaresan, N.R., Gupta, M.P., Geenen, D.L., Solaro, R.J., Gupta, M., A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J. Biol. Chem. 288 (2013), 11216–11232.
67. [67] Knezevic, I., Patel, A., Sundaresan, N.R., Gupta, M.P., Solaro, R.J., Nagalingam, R.S., Gupta, M., A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival. J. Biol. Chem. 287 (2012), 12913–12926.
68. [68] Sadegh, M.K., Ekman, M., Rippe, C., Uvelius, B., Sward, K., Albinsson, S., Deletion of dicer in smooth muscle affects voiding pattern and reduces detrusor contractility and neuroeffector transmission. PLoS One, 7, 2012, e35882.
69. [69] Eichner, L.J., Perry, M.C., Dufour, C.R., Bertos, N., Park, M., St-Pierre, J., Giguere, V., miR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1beta/ERRgamma transcriptional pathway. Cell Metab. 12 (2010), 352–361.
70. [70] Small, E.M., Olson, E.N., Pervasive roles of microRNAs in cardiovascular biology. Nature 469 (2011), 336–342.
71. [71] Carrer, M., Liu, N., Grueter, C.E., Williams, A.H., Frisard, M.I., Hulver, M.W., Bassel-Duby, R., Olson, E.N., Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 15330–15335.
72. [72] Sward, K., Stenkula, K.G., Rippe, C., Alajbegovic, A., Gomez, M.F., Albinsson, S., Emerging roles of the myocardin family of proteins in lipid and glucose metabolism. J. Physiol., 2016.
73. [73] Ganesan, J., Ramanujam, D., Sassi, Y., Ahles, A., Jentzsch, C., Werfel, S., Leierseder, S., Loyer, X., Giacca, M., Zentilin, L., Thum, T., Laggerbauer, B., Engelhardt, S., MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 127 (2013), 2097–2106.
74. [74] Huang, Z.P., Chen, J., Seok, H.Y., Zhang, Z., Kataoka, M., Hu, X., Wang, D.Z., MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 112 (2013), 1234–1243.
75. [75] Gurha, P., Abreu-Goodger, C., Wang, T., Ramirez, M.O., Drumond, A.L., van Dongen, S., Chen, Y., Bartonicek, N., Enright, A.J., Lee, B., Kelm, R.J. Jr., Reddy, A.K., Taffet, G.E., Bradley, A., Wehrens, X.H., Entman, M.L., Rodriguez, A., Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 125 (2012), 2751–2761.
76. [76] Zhao, H., Wen, G., Huang, Y., Yu, X., Chen, Q., Afzal, T.A., Luong le, A., Zhu, J., Shu, Y., Zhang, L., Xiao, Q., MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 918–929.
77. [77] Zeidan, A., Nordstrom, I., Albinsson, S., Malmqvist, U., Sward, K., Hellstrand, P., Stretch-induced contractile differentiation of vascular smooth muscle: sensitivity to actin polymerization inhibitors. Am. J. Physiol. Cell Physiol. 284 (2003), C1387–C1396.
78. [78] Forte, A., Della Corte, A., Grossi, M., Bancone, C., Provenzano, R., Finicelli, M., De Feo, M., De Santo, L.S., Nappi, G., Cotrufo, M., Galderisi, U., Cipollaro, M., Early cell changes and TGFbeta pathway alterations in the aortopathy associated with bicuspid aortic valve stenosis. Clin. Sci. (Lond.) 124 (2013), 97–108.
79. [79] Guo, D.C., Pannu, H., Tran-Fadulu, V., Papke, C.L., Yu, R.K., Avidan, N., Bourgeois, S., Estrera, A.L., Safi, H.J., Sparks, E., Amor, D., Ades, L., McConnell, V., Willoughby, C.E., Abuelo, D., Willing, M., Lewis, R.A., Kim, D.H., Scherer, S., Tung, P.P., Ahn, C., Buja, L.M., Raman, C.S., Shete, S.S., Milewicz, D.M., Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39 (2007), 1488–1493.
80. [80] Vengrenyuk, Y., Nishi, H., Long, X., Ouimet, M., Savji, N., Martinez, F.O., Cassella, C.P., Moore, K.J., Ramsey, S.A., Miano, J.M., Fisher, E.A., Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 535–546.